Patents by Inventor Shankar Sanganabhatla

Shankar Sanganabhatla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8450376
    Abstract: The present invention provides an amorphous bupropion hydrobromide and an amorphous bupropion hydrobromide granulates with at least one pharmaceutically acceptable carrier, and a process for its preparation.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: May 28, 2013
    Assignee: Glenmark Generics Ltd.
    Inventors: Shankar Sanganabhatla, Vijay Soni, Mubeen Ahmed Khan, Nandlal Agarwal, Hemanth Kamble, Sharad Gore
  • Publication number: 20110312977
    Abstract: The present invention provides a process for preparation of racemic voriconazole in a single reaction vessel. The present invention also provides a process for preparation of voriconazole using racemic voriconazole and the process of making it therewith.
    Type: Application
    Filed: February 4, 2010
    Publication date: December 22, 2011
    Applicant: GLENMARK GENERICS LIMITED
    Inventors: Francis Paul D'Souza, Premkumar Ramraj Yadav, Shankar Sanganabhatla, Mubeen Ahmed Khan
  • Publication number: 20110105619
    Abstract: The present invention provides an amorphous bupropion hydrobromide and an amorphous bupropion hydrobromide granulates with at least one pharmaceutically acceptable carrier, and a process for its preparation.
    Type: Application
    Filed: June 15, 2009
    Publication date: May 5, 2011
    Applicant: Glenmark Generics Ltd.
    Inventors: Shankar Sanganabhatla, Vijay Soni, Mubeen Ahmed Khan, Nandlal Agarwal, Hemanth Kamble, Sharad Gore
  • Publication number: 20100310870
    Abstract: The present invention relates to amorphous form of bazedoxifene acetate and a process for the preparation thereof.
    Type: Application
    Filed: March 16, 2010
    Publication date: December 9, 2010
    Applicant: GLENMARK GENERICS LTD.
    Inventors: Shankar Sanganabhatla, Sachin Srivastava, Dinesh Bansilal Deore, Anthony Melvin Crasto, Mubeen Ahmed Khan
  • Patent number: 7763645
    Abstract: Disclosed herein is crystalline carvedilol dihydrogen phosphate monohydrate having high aqueous solubility and the process for preparation thereof. The invention further discloses methods for treating hypertension, congestive heart failure and angina in a mammal, using pharmaceutical compositions comprising the compound of invention.
    Type: Grant
    Filed: October 8, 2008
    Date of Patent: July 27, 2010
    Assignee: Wanbury Limited
    Inventors: Shankar Sanganabhatla, Sunanda Manoj, Ramanarasimha Moorthy Koduru
  • Publication number: 20090291997
    Abstract: Disclosed herein is crystalline carvedilol dihydrogen phosphate monohydrate having high aqueous solubility and the process for preparation thereof. The invention further discloses methods for treating hypertension, congestive heart failure and angina in a mammal, using pharmaceutical compositions comprising the compound of invention.
    Type: Application
    Filed: October 8, 2008
    Publication date: November 26, 2009
    Applicant: WANBURY LIMITED
    Inventors: Shankar Sanganabhatla, Sunanda Manoj, Ramanarasimha Moorthy Koduru